227 related articles for article (PubMed ID: 37310732)
1. Coregulation of extracellular vesicle production and fluconazole susceptibility in
Rizzo J; Trottier A; Moyrand F; Coppée JY; Maufrais C; Zimbres ACG; Dang TTV; Alanio A; Desnos-Ollivier M; Mouyna I; Péhau-Arnaude G; Commere PH; Novault S; Ene IV; Nimrichter L; Rodrigues ML; Janbon G
mBio; 2023 Aug; 14(4):e0087023. PubMed ID: 37310732
[TBL] [Abstract][Full Text] [Related]
2. Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase.
Carvajal SK; Melendres J; Escandón P; Firacative C
Microbiol Spectr; 2023 Aug; 11(4):e0140323. PubMed ID: 37341584
[TBL] [Abstract][Full Text] [Related]
3. Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence.
Sionov E; Chang YC; Garraffo HM; Kwon-Chung KJ
Antimicrob Agents Chemother; 2009 Jul; 53(7):2804-15. PubMed ID: 19414582
[TBL] [Abstract][Full Text] [Related]
4. Cryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomes.
Sionov E; Lee H; Chang YC; Kwon-Chung KJ
PLoS Pathog; 2010 Apr; 6(4):e1000848. PubMed ID: 20368972
[TBL] [Abstract][Full Text] [Related]
5. Lipid Flippase Subunit Cdc50 Mediates Drug Resistance and Virulence in Cryptococcus neoformans.
Huang W; Liao G; Baker GM; Wang Y; Lau R; Paderu P; Perlin DS; Xue C
mBio; 2016 May; 7(3):. PubMed ID: 27165800
[TBL] [Abstract][Full Text] [Related]
6. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.
Basso LR; Gast CE; Bruzual I; Wong B
J Antimicrob Chemother; 2015 May; 70(5):1396-407. PubMed ID: 25630649
[TBL] [Abstract][Full Text] [Related]
7. Colony and Single Cell Level Analysis of the Heterogeneous Response of
Altamirano S; Simmons C; Kozubowski L
Front Cell Infect Microbiol; 2018; 8():203. PubMed ID: 29971221
[No Abstract] [Full Text] [Related]
8. A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs.
Kim J; Cho YJ; Do E; Choi J; Hu G; Cadieux B; Chun J; Lee Y; Kronstad JW; Jung WH
Fungal Genet Biol; 2012 Nov; 49(11):955-66. PubMed ID: 22975303
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole.
Sionov E; Chang YC; Garraffo HM; Dolan MA; Ghannoum MA; Kwon-Chung KJ
Antimicrob Agents Chemother; 2012 Mar; 56(3):1162-9. PubMed ID: 22155829
[TBL] [Abstract][Full Text] [Related]
10. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
Yang F; Gritsenko V; Lu H; Zhen C; Gao L; Berman J; Jiang YY
Microbiol Spectr; 2021 Oct; 9(2):e0072321. PubMed ID: 34585947
[TBL] [Abstract][Full Text] [Related]
11. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
[TBL] [Abstract][Full Text] [Related]
12. Activity of VT-1129 against Cryptococcus neoformans clinical isolates with high fluconazole MICs.
Nielsen K; Vedula P; Smith KD; Meya DB; Garvey EP; Hoekstra WJ; Schotzinger RJ; Boulware DR
Med Mycol; 2017 Jun; 55(4):453-456. PubMed ID: 27664991
[TBL] [Abstract][Full Text] [Related]
13. Investigation of fluconazole heteroresistance in clinical and environmental isolates of Cryptococcus neoformans complex and Cryptococcus gattii complex in the state of Amazonas, Brazil.
Moreira IMB; Cortez ACA; de Souza ÉS; Pinheiro SB; de Souza Oliveira JG; Sadahiro A; Cruz KS; Matsuura ABJ; Melhem MSC; Frickmann H; de Souza JVB
Med Mycol; 2022 Mar; 60(3):. PubMed ID: 35084497
[TBL] [Abstract][Full Text] [Related]
14. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
Bosco-Borgeat ME; Mazza M; Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G
Rev Argent Microbiol; 2016; 48(2):137-42. PubMed ID: 27311753
[TBL] [Abstract][Full Text] [Related]
15. Cryptococcus neoformans, Unlike Candida albicans, Forms Aneuploid Clones Directly from Uninucleated Cells under Fluconazole Stress.
Chang YC; Khanal Lamichhane A; Kwon-Chung KJ
mBio; 2018 Dec; 9(6):. PubMed ID: 30514783
[TBL] [Abstract][Full Text] [Related]
16. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.
Mansfield BE; Oltean HN; Oliver BG; Hoot SJ; Leyde SE; Hedstrom L; White TC
PLoS Pathog; 2010 Sep; 6(9):e1001126. PubMed ID: 20941354
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a Cryptococcus neoformans ATP binding cassette (ABC) transporter-encoding gene, CnAFR1, involved in the resistance to fluconazole.
Posteraro B; Sanguinetti M; Sanglard D; La Sorda M; Boccia S; Romano L; Morace G; Fadda G
Mol Microbiol; 2003 Jan; 47(2):357-71. PubMed ID: 12519188
[TBL] [Abstract][Full Text] [Related]
18. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner.
Semighini CP; Averette AF; Perfect JR; Heitman J
PLoS Pathog; 2011 Nov; 7(11):e1002364. PubMed ID: 22114551
[TBL] [Abstract][Full Text] [Related]
20. Roles of Three Cryptococcus neoformans and Cryptococcus gattii Efflux Pump-Coding Genes in Response to Drug Treatment.
Chang M; Sionov E; Khanal Lamichhane A; Kwon-Chung KJ; Chang YC
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378705
[No Abstract] [Full Text] [Related]
[Next] [New Search]
